Federated Hermes, Inc. Laboratory Corp Of America Holdings Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$209.01 - $232.56 $4,807 - $5,348	-23 Reduced 6.85%	313 $68,000
Q4 2023 Jan 31, 2024	SELL	$197.69 - $227.29 $3,756 - $4,318	-19 Reduced 5.35%	336 $76,000
Q3 2023 Nov 13, 2023	SELL	$201.05 - $221.7 $64,537 - $71,165	-321 Reduced 47.49%	355 $71,000
Q2 2023 Aug 14, 2023	BUY	$211.93 - $241.33 $14,835 - $16,893	70 Added 11.55%	676 $163,000
Q1 2023 May 08, 2023	SELL	$213.32 - $257.83 $94,287 - $113,960	-442 Reduced 42.18%	606 $139,000
Q4 2022 Feb 13, 2023	SELL	$203.72 - $248.97 $138,529 - $169,299	-680 Reduced 39.35%	1,048 $246,000
Q3 2022 Nov 14, 2022	SELL	$204.81 - $262.19 $18,023 - $23,072	-88 Reduced 4.85%	1,728 $354,000
Q2 2022 Aug 15, 2022	SELL	$213.86 - $277.87 $420,234 - $546,014	-1,965 Reduced 51.97%	1,816 $426,000
Q1 2022 May 13, 2022	SELL	$259.82 - $298.18 $4,416 - $5,069	-17 Reduced 0.45%	3,781 $997,000
Q4 2021 Feb 14, 2022	BUY	$271.6 - $314.21 $287,624 - $332,748	1,059 Added 38.66%	3,798 $1.19 Million
Q3 2021 Nov 15, 2021	BUY	$274.82 - $308.34 $37,100 - $41,625	135 Added 5.18%	2,739 $771,000
Q2 2021 Aug 16, 2021	BUY	$251.87 - $278.14 $469,233 - $518,174	1,863 Added 251.42%	2,604 $718,000
Q1 2021 May 13, 2021	SELL	$204.88 - $255.03 $5,122 - $6,375	-25 Reduced 3.26%	741 $189,000
Q4 2020 Feb 12, 2021	SELL	$186.91 - $214.42 $39,998 - $45,885	-214 Reduced 21.84%	766 $156,000
Q3 2020 Nov 12, 2020	SELL	$167.03 - $201.3 $25,054 - $30,195	-150 Reduced 13.27%	980 $184,000
Q2 2020 Aug 13, 2020	BUY	$113.31 - $182.44 $34,559 - $55,644	305 Added 36.97%	1,130 $188,000
Q1 2020 May 13, 2020	SELL	$104.32 - $195.28 $8,658 - $16,208	-83 Reduced 9.14%	825 $104,000
Q4 2019 Feb 14, 2020	SELL	$163.48 - $173.61 $77,653 - $82,464	-475 Reduced 34.35%	908 $154,000
Q3 2019 Nov 14, 2019	BUY	$159.77 - $178.1 $1,437 - $1,602	9 Added 0.66%	1,383 $232,000
Q2 2019 Aug 14, 2019	BUY	$144.16 - $172.9 $155,692 - $186,732	1,080 Added 367.35%	1,374 $238,000
Q1 2019 May 10, 2019	SELL	$123.7 - $156.3 $263,481 - $332,919	-2,130 Reduced 87.87%	294 $45,000
Q4 2018 Feb 13, 2019	BUY	$120.82 - $174.09 $123,478 - $177,919	1,022 Added 72.9%	2,424 $306,000
Q3 2018 Nov 13, 2018	SELL	$167.67 - $188.27 $5,533 - $6,212	-33 Reduced 2.3%	1,402 $243,000
Q2 2018 Aug 10, 2018	SELL	$160.33 - $189.41 $36,074 - $42,617	-225 Reduced 13.55%	1,435 $258,000
Q1 2018 May 09, 2018	SELL	$161.53 - $178.11 $707,178 - $779,765	-4,378 Reduced 72.51%	1,660 $269,000
Q4 2017 Feb 14, 2018	BUY	$147.99 - $163.95 $305,895 - $338,884	2,067 Added 52.05%	6,038 $0
Q3 2017 Nov 13, 2017	BUY	$149.47 - $160.56 $593,545 - $637,583	3,971	3,971 $599,000

Others Institutions Holding LH

# of Institutions

Shares Held

1.94M

Call Options Held

Put Options Held

View Full List

About LABORATORY CORP OF AMERICA HOLDINGS

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $22.1B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

More about LH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account